Synopsis of recent research by authors named "Ana de Juan"
Ana de Juan's research primarily focuses on ovarian and breast cancer, exploring safety, effectiveness, and prognostic factors associated with different treatment approaches within varied patient populations across Spain.
The studies include real-world data analysis, such as the effectiveness of maintenance niraparib for recurrent ovarian cancer and dietary factors influencing breast cancer risk, indicating a commitment to improving clinical outcomes through evidence-based practices.
Collaborative efforts, like the Prospective Real-World Gynaecological Cancer Clinical Registry, highlight the importance of biobanks and patient registries in facilitating translational research and enhancing treatment strategies for gynecological cancers.
